A 2024 retrospective cohort analysis published in Diabetes, Obesity and Metabolism (N=312 patients who switched from semaglutide to tirzepatide at a single academic center) found that switchers lost an additional mean of 6.3% of body weight over 6 months after the switch, with 68% reporting either stable or improved GI tolerability [12]
Many glutathione patients also add our NAD+ IV therapy for energy, the Myers Cocktail IV for broad nutrient support, or IV hydration and recovery after travel or training
JH: Conceptualization, Funding acquisition, Visualization, Writing review and editing
(2) integrating synergistic effects of glycemic, weight, and blood pressure reductions over a 25-year horizon
However, a 2024 study analyzing global pharmacovigilance data found a higher-than-expected number of suicidal ideation reports among semaglutide users compared to other diabetes medications
N-terminal fragment of c-FLIP (L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-B signaling pathway